| Financial Year |
March 31 2023 |
| Monetary Funds |
62,503,991.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
88,004,618.55 |
| Advances to Suppliers |
11,549,596.52 |
| Other Receivables |
38,040,390.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,662,173.69 |
| Total Current Assets |
236,760,771.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,043,365.07 |
| Investment Properties |
-- |
| Fixed Assetes |
233,504,263.75 |
| Under-construction Projects |
87,517,159.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,473,446.49 |
| R&D expenses |
-- |
| Goodwill |
11,982,176.28 |
| Long-Term Deferred and Prepaid Expenses |
2,784,168.65 |
| Deferred Income Tax Assets |
41,801,372.95 |
| Other Non-Current Assets |
188,118.60 |
| Sub-Total of Non-Current Assets |
698,536,402.73 |
| Total Assets |
935,297,173.81 |
| Short-Term Loans |
80,131,422.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
92,109,286.30 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,344,258.15 |
| Taxes Payable |
37,084,704.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
51,603,478.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,400,284.62 |
| Other Current Liabilities |
181,973.91 |
| Sub-Total of Current Liabilities |
304,053,962.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
23,905,412.50 |
| Deferred Income Tax Liabilities |
19,561,901.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
88,676,743.34 |
| Total Liabilities |
392,730,705.81 |
| Paid-In Capital(Or Share Stock) |
261,858,710.00 |
| Capital Surplus |
390,152,808.76 |
| Surplus Reserve |
55,838,543.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-83,893,321.72 |
| Minority Stockholder's Interest |
-25,404,365.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
567,970,833.25 |
| Owner's Equity(Stockholder's Equity) |
542,566,468.00 |
| Total Liabilities and Owner's Equity(Stockholder's Equity) |
935,297,173.81 |